COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic
- PMID: 32224232
- PMCID: PMC7195089
- DOI: 10.1016/j.jaip.2020.03.012
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic
Abstract
In the event of a global infectious pandemic, drastic measures may be needed that limit or require adjustment of ambulatory allergy services. However, no rationale for how to prioritize service shut down and patient care exists. A consensus-based ad-hoc expert panel of allergy/immunology specialists from the United States and Canada developed a service and patient prioritization schematic to temporarily triage allergy/immunology services. Recommendations and feedback were developed iteratively, using an adapted modified Delphi methodology to achieve consensus. During the ongoing pandemic while social distancing is being encouraged, most allergy/immunology care could be postponed/delayed or handled through virtual care. With the exception of many patients with primary immunodeficiency, patients on venom immunotherapy, and patients with asthma of a certain severity, there is limited need for face-to-face visits under such conditions. These suggestions are intended to help provide a logical approach to quickly adjust service to mitigate risk to both medical staff and patients. Importantly, individual community circumstances may be unique and require contextual consideration. The decision to enact any of these measures rests with the judgment of each clinician and individual health care system. Pandemics are unanticipated, and enforced social distancing/quarantining is highly unusual. This expert panel consensus document offers a prioritization rational to help guide decision making when such situations arise and an allergist/immunologist is forced to reduce services or makes the decision on his or her own to do so.
Keywords: Allergic rhinitis; Allergy; Allergy immunotherapy; Angioedema; Asthma; Atopic dermatitis; COVID-19; Food allergy; Primary immunodeficiency; SARS-CoV-2; Urticaria; Venom allergy.
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
JACI: In Practice Response to COVID-19 Pandemic.J Allergy Clin Immunol Pract. 2020 May;8(5):1475-1476. doi: 10.1016/j.jaip.2020.03.027. Epub 2020 Apr 6. J Allergy Clin Immunol Pract. 2020. PMID: 32272283 Free PMC article. No abstract available.
-
Subcutaneous terbutaline as an alternative to aerosolized albuterol.J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2450. doi: 10.1016/j.jaip.2020.04.015. Epub 2020 Apr 20. J Allergy Clin Immunol Pract. 2020. PMID: 32336646 Free PMC article. No abstract available.
-
Reply to "Subcutaneous terbutaline as an alternative to aerosolized albuterol".J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2450-2452. doi: 10.1016/j.jaip.2020.04.016. Epub 2020 Apr 22. J Allergy Clin Immunol Pract. 2020. PMID: 32340824 Free PMC article. No abstract available.
-
Debate on drugs that may aggravate COVID-19.J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2452-2453. doi: 10.1016/j.jaip.2020.04.037. Epub 2020 Apr 25. J Allergy Clin Immunol Pract. 2020. PMID: 32344190 Free PMC article. No abstract available.
-
CORONAVIRUS (COVID-19) PANDEMIC: PERSONAL VIEW TO A NEW MODEL OF PAEDIATRIC PRACTICE.J Paediatr Child Health. 2020 Jun;56(6):995. doi: 10.1111/jpc.14958. J Paediatr Child Health. 2020. PMID: 32567773 Free PMC article. No abstract available.
-
Real-life experience of an allergy and clinical immunology department in a Portuguese reference COVID-19 hospital.J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3671-3672. doi: 10.1016/j.jaip.2020.08.042. Epub 2020 Sep 2. J Allergy Clin Immunol Pract. 2020. PMID: 32890757 Free PMC article. No abstract available.
-
What a Dime Can Buy You.J Allergy Clin Immunol Pract. 2021 Jul;9(7):2669-2671. doi: 10.1016/j.jaip.2021.04.032. Epub 2021 Apr 26. J Allergy Clin Immunol Pract. 2021. PMID: 33915309 No abstract available.
References
-
- Del Rio C., Malani P.N. COVID-19—new insights on a rapidly changing epidemic. JAMA. 2020;323:1339–1340. - PubMed
-
- Centers for Disease Control and Prevention Coronaviurs disease 2019 (COVID-19) situation summary. https://www.cdc.gov/coronavirus/2019-ncov/index.html Available from:
-
- Novel Coronaviurs Information Center https://www.elsevier.com/connect/coronavirus-information-center Available from:
-
- Coronavirus COVID-19 global cases by the Center for Systems Science and Engineering at Johns Hopkins University. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594... Available from:
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous